SCHEMBL7109686

SCHEMBL7109686

CCCCCc1cnc2ccccc2n1

nearest known ligand 0.69

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 7/20 0.69
KCNH2 Q12809 1/20 0.52
MAPT P10636 2/20 0.50
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
KDM4E B2RXH2 1/20 0.49
NPC1 O15118 1/20 0.49
ALDH1A1 P00352 1/20 0.49
HPGD P15428 1/20 0.49
RAB9A P51151 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
TLR7 Q9NYK1 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2C9 P11712 1/20 0.46
HIF1A Q16665 1/20 0.46
TLR8 Q9NR97 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14795853 0.98 PDE10A (0.67) PDE10AKCNH2MAPTMEN1KMT2A
SCHEMBL27964546 0.98 PDE10A (0.67) PDE10AKCNH2MAPTMEN1KMT2A
SCHEMBL28236348 0.98 PDE10A (0.67) PDE10AKCNH2MAPTMEN1KMT2A
SCHEMBL28001709 0.98 PDE10A (0.67) PDE10AKCNH2MAPTMEN1KMT2A
SCHEMBL28524344 0.98 PDE10A (0.67) PDE10AKCNH2MAPTMEN1KMT2A
SCHEMBL28001999 0.98 PDE10A (0.67) PDE10AKCNH2MAPTMEN1KMT2A
SCHEMBL28236355 0.98 PDE10A (0.67) PDE10AKCNH2MAPTMEN1KMT2A
SCHEMBL7068584 0.95 PDE10A (0.71) PDE10AKCNH2MAPTMEN1KMT2A
SCHEMBL9971272 0.87 PDE10A (0.77) PDE10AMAPTMEN1KMT2AKDM4E
SCHEMBL12066225 0.82 PDE10A (1.00) PDE10AMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114524773-B Synthesis method of aryl quinoxaline compound promoted by mechanical force 浙江工业大学 2024-05-28 CN claimed
CN-114524773-A Method for synthesizing aryl quinoxaline compound promoted by mechanical force 浙江工业大学 2022-05-24 CN claimed
WO-2012122605-A1 IRIDIUM BASED COMPLEX FOR WATER SPLITTING THE UNIVERSITY OF QUEENSLAND (AU) 2012-09-20 WO claimed
CN-102617833-A Quinoxaline porphyrin unit based conjugated polymer as well as preparation method and application thereof UNIV BEIJING CHEMICAL 2012-08-01 CN claimed
US-4304898-A HEAT RESIST METAL WIRE COATINGS INSTITUT FRANCAIS DU PETROLE (FR) 1981-12-08 US claimed
CN-114524773-B Synthesis method of aryl quinoxaline compound promoted by mechanical force 浙江工业大学 2024-05-28 CN disclosed
CN-114524773-B Synthesis method of aryl quinoxaline compound promoted by mechanical force 浙江工业大学 2024-05-28 CN disclosed
CN-114524773-B Synthesis method of aryl quinoxaline compound promoted by mechanical force 浙江工业大学 2024-05-28 CN disclosed
CN-114524773-A Method for synthesizing aryl quinoxaline compound promoted by mechanical force 浙江工业大学 2022-05-24 CN disclosed
CN-114524773-A Method for synthesizing aryl quinoxaline compound promoted by mechanical force 浙江工业大学 2022-05-24 CN disclosed
CN-114524773-A Method for synthesizing aryl quinoxaline compound promoted by mechanical force 浙江工业大学 2022-05-24 CN disclosed
CN-110423255-B Deep red light electrophosphorescent material based on monoaryl substituted quinoxaline cyclometalated iridium (III) complex and application thereof 常州大学 2022-03-01 CN disclosed
US-20030149038-A1 Alpha-helix mimicry by a class of organic molecules THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2003-08-07 US disclosed
WO-2003040402-A2 ALPHA-HELIX MIMICRY BY A CLASS OF ORGANIC MOLECULES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2003-05-15 WO disclosed
EP-0860433-B1 QUINOLINE DERIVATIVES AND QUINAZOLINE DERIVATIVES INHIBITING AUTOPHOSPHORYLATION OF GROWTH FACTOR RECEPTOR ORIGINATING IN PLATELET AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME KIRIN BREWERY (JP) 2002-07-03 EP disclosed
US-6143764-A ETHER DERIVATIVES OF QUINOLINE, ANTITUMOR AGENTS KIRIN BEER KABUSHIKI KAISHA (JP) 2000-11-07 US disclosed
EP-0860433-A1 QUINOLINE DERIVATIVES AND QUINAZOLINE DERIVATIVES INHIBITING AUTOPHOSPHORYLATION OF GROWTH FACTOR RECEPTOR ORIGINATING IN PLATELET AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME KIRIN BEER KABUSHIKI KAISHA (JP) 1998-08-26 EP disclosed
US-4304898-A HEAT RESIST METAL WIRE COATINGS INSTITUT FRANCAIS DU PETROLE (FR) 1981-12-08 US disclosed
US-4304898-A HEAT RESIST METAL WIRE COATINGS INSTITUT FRANCAIS DU PETROLE (FR) 1981-12-08 US disclosed
US-4304898-A HEAT RESIST METAL WIRE COATINGS INSTITUT FRANCAIS DU PETROLE (FR) 1981-12-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030149038-A1 Alpha-helix mimicry by a class of organic molecules SERPINH1, FABP1, HSPH1 PDE10A 3385/4885KCNH2 3448/4885MAPT 798/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.